Fosun

Fosun, a Chinese pharmaceutical preparation manufacturing company, reported approximately 1.55 billion kg CO2e in combined Scope 1 and Scope 2 emissions for 2023. In 2022, the company disclosed Scope 1 emissions of about 17.77 billion kg CO2e, Scope 2 emissions of approximately 2.92 billion kg CO2e, and Scope 3 emissions of roughly 65.05 million kg CO2e. For 2021, Fosun's Scope 1 emissions were around 19.09 billion kg CO2e, Scope 2 emissions approximately 2.88 billion kg CO2e, and Scope 3 emissions about 9.83 million kg CO2e. In 2020, Scope 1 emissions were approximately 19.60 billion kg CO2e, Scope 2 emissions about 2.53 billion kg CO2e, and Scope 3 emissions approximately 1.14 million kg CO2e. In 2019, combined Scope 1 and Scope 2 emissions were about 21.51 billion kg CO2e, with Scope 1 at approximately 18.69 billion kg CO2e and Scope 2 at roughly 2.82 billion kg CO2e. The earliest reported data for 2018 shows Scope 1 emissions of about 786.37 million kg CO2e. Fosun has not publicly disclosed specific carbon reduction targets.